Gene Query: HIST1H3A

Dataset Description Geneva Score
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 119.27
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 59.95
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 59.71
Impact of dieldrin on transcription in Jurkat T cells 58.99
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 55.86
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 55.86
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 47.97
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 46.26
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 44.23
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 44.23
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 43.85
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 43.82
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 43.0
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 42.74
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 40.26
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 39.6
Next generation sequencing identifies discrete classes of box C/D snoRNAs featuring different ends and RNA binding protein dependency 36.71
Retinoic acid suppresses MYB in adenoid cystic carcinoma 32.78
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 32.78
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 31.97
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 31.43
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 30.16
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 29.67
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 28.51
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 28.11
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 27.59
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 26.49
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 26.26
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 25.6
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 25.6
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 24.65
RNA-seq of resting and activated CD4+ T cells +-JQ1 24.4
U1 snRNP telescripting regulates size-function stratified human genome 24.12
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 23.51
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 23.24
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 23.23
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 23.19
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 22.87
CD95/Fas ligand mRNA is toxic to cells 22.66
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 21.78
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 21.32
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 21.12
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 21.12
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 20.41
Real-time observation of light-controlled transcription in living cells 20.04
Tracking distinct RNA populations using efficient and reversible covalent chemistry 19.37
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 19.22
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 18.78
RNA-Seq with and without RNase treatment in PCa cell lines 18.76
Gene induction by the USP6 oncogene in response to interferon 18.67
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 18.64
Endothelial gene expression analysis 18.34
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 18.34
MYCi361 regulates MYC target genes 18.16
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 18.09
Studying the selectivity of a small molecule Synucleozid on transcriptome 18.05
circRNA profile in hypopharyngeal cancer 17.95
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 17.81
Zika infected neural stem cells 16.29
Transcriptome analysis of Zika infected neural stem cells 16.29
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 15.92
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 15.78
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 15.76
Genome-wide discovery of human splicing branchpoints 15.48
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 15.43
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 15.26
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 15.2
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 15.19
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 15.03
p53 activity results in DNA replication fork processivity 14.84
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 14.76
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 14.75
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 14.75
Accurate annotation of human protein-coding small open reading frames 14.72
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 14.7
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 14.7
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 14.53
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 14.29
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 14.26
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 14.02
Transcriptome landscape of HeLa response upon triamcinolone acetonide 13.94
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 13.78
Ribosomal footprinting of CN34-Parental and CN34-LM1a 13.71
Differentially expressed genes post knock down of lincDUSP26 13.23
NRDE2 negatively regulates nuclear exosome functions 13.06
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 12.94
SRSF1 role in cellular gene expression and splicing 12.87
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 12.84
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 12.55
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 12.36
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 12.36
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 12.17
Universal alternative splicing of noncoding exons 12.15
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 12.09
Ribosomal footprinting of MDA-Parental and MDA-LM2 12.0
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 11.98
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 11.68
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 11.68
Genome-wide discovery of human splicing branchpoints [RNAse] 11.65
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 11.6
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 11.55
LncRNA expression profiling of ischemic stroke patients 11.1
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 11.07
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 10.99
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 10.92
CircRNAome diversity in human mature B-cells, T-cells and monocytes 10.8
Role for citron kinase in prostate cancer growth 10.76
Expression and functions of long noncoding RNAs during human T helper cell differentiation 10.75
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 10.66
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 10.66
Uridylation by TUT4 and TUT7 marks mRNA for degradation 10.56
Transcriptome analysis upon C6orf203 silencing 10.55
Hijacking of stress response machinery by oncogenes in acute leukaemia 10.45
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 10.45
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 10.45
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 10.4
Epigenome regulation during epidermal lineage commitment 10.33
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 10.24
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 10.17
Transcriptome analysis of H9 hESC derived cerebral organoids 10.08
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 9.96
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 9.95
Genome wide miR-191 target profile determined by RIP and gene expression profiling 9.84
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 9.84
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 9.8
Gene expression changes caused by KRAS in MCF-10A 9.79
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 9.67
Expression profiles of the four human major ectodermal lineages 9.64
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 9.61
A role for ZNF598 in post-transcriptional gene regulation 9.53
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 9.49
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 9.49
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 9.16
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 9.12
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 9.06
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 9.05
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 9.05
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 9.05
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 8.92
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 8.83
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 8.61
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 8.6
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 8.52
Identification of long noncoding RNAs regulated by p53 8.48
Effect of BB608 on Gene Expression in HNSCC Cell Line 8.48
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 8.31
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 8.15
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 8.15
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 8.14
Cajal bodies are linked to genome conformation 8.08
Cajal bodies are linked to genome conformation [RNA-Seq] 8.08
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 7.99
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 7.97
Systematic discovery of endogenous human ribonucleoprotein complexes 7.97
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 7.8
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 7.75
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 7.75
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 7.59
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 7.59
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 7.55
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 7.47
Codon usage optimization in pluripotent embryonic stem cells [tRNA sequencing] 7.42
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 7.42
Landscape and variation of RNA secondary structure across the human transcriptome 7.38
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 7.25
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 7.18
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 7.18
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 7.1
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 7.05
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 7.05
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 7.04
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 7.02
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 7.02
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 7.02
Total RNA-seq in ALL-SIL upon JQ1 inhibition 6.97
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 6.86
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 6.79
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 6.76
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 6.76
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 6.73
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 6.68
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 6.64
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 6.61
p63 controls the enhancer landscape during keratinocyte differentiation 6.57
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 6.55
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 6.52
Mapping interactions for the TNIP2 hub protein 6.36
Short and Long RNA sequencing of human mature erythrocytes 6.35
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 6.33
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 6.32
The interplay between SOX4 and SMAD3 in the context of breast cancer 6.25
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 6.24
Next Generation Sequencing Compares Effects of microRNA-9 perturbation in control and SZ hiPSC NPCs 6.19
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 6.19
Differential responses of human fetal brain neural stem cells to Zika virus infection 6.15
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 6.11
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 6.1
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 6.1
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 5.98
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 5.98
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 5.89
Selective expression of long non-coding RNAs in a breast cancer cell progression model 5.87
Oncogenic MYC induces a dependency on the spliceosome in human cancer 5.86
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 5.84
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 5.76
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 5.73
Identification of HOXB13 target genes responsive to BET inhibitors 5.71
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 5.7
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 5.69
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 5.69
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 5.69
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 5.61
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 5.55
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 5.53
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 5.53
Differentiation enhances Zika virus infection in neuronal brain cells 5.51
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 5.49
Tyrosine Kinase Inhibitor Cardiotoxicity 5.49
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 5.32
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 5.29
Glioblastoma stem cells infected by ZIKA virus 5.25
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 5.19
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 5.18
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 5.17
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  5.13
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 5.1
RNA-Seq from early time points in the kidney differentiation protocol 5.1
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 5.09
An RNA-centric dissection of host complexes controlling flavivirus infection 5.03
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 5.03
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 4.96
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 4.93
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 4.92
Reassessment of Exosome Composition 4.91
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 4.91
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 4.83
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 4.82
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 4.8
4.8
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 4.77
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 4.76
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 4.76
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 4.71
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 4.68
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 4.68
MYC dependent mRNA translation shapes gene expression and cell biology 4.67
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 4.63
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 4.59
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 4.58
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 4.58
ADAR1-editing of cellular and measles virus-derived duplex RNA 4.58
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 4.58
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 4.57
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 4.57
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 24h] 4.52
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 4.51
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 4.49
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 4.4
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 4.4
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 4.39
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 4.35
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 4.32
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 4.26
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 4.25
The conserved transcriptional landscapes in human spermatogenesis 4.25
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 4.2
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 4.17
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 4.15
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 4.14
Gene expression profile of human iPSC-derived nephron progenitor cells 4.11
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 4.09
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 4.09
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 4.03
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 4.03
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 4.03
RIG-I and MDA5 fRIP during KSHV lytic reactivation 4.0
Enhancer activation during EGF response 3.97
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 3.96
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 3.94
Loss of CREBBP results in gene expression repression in lymphoma cells 3.94
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 3.93
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 3.86
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 3.85
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 3.84
RNA polymerase in pre-B-ALL cell lines 3.82
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 3.82
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 3.77
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 3.71
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 3.71
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 3.69
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 3.66
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 3.62
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 3.6
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 3.57
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 3.57
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 3.55
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 3.55
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 3.52
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 3.52
LIN28A Over-expression RNAseq 3.51
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 3.47
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 3.46
4sUDRB-seq: measuring transcription elongation and initiation genomewide 3.44
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 3.38
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 3.38
Gene expression analysis in response to hypoxic pathway inhibition 3.37
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 3.34
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 3.32
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 3.32
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 3.26
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 3.26
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 3.25
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 3.21
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 3.21
Landscape of H3K4me3 in human CD19 cells 3.21
Ribosomal protein RPL26 is the principal target of UFMylation 3.2
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 3.15
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 3.14
Characterisation of the EZH2 regulated transcriptome in de novo transformed cells (RNA-Seq) 3.13
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 3.1
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 3.1
Genome-wide mapping of TEL-AML1 targets in acute leukemia 3.08
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 3.03
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 3.02
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 3.0
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 3.0
6mer seed toxicity in tumour suppressive microRNAs 3.0
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription [RNA-Seq] 2.99
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription 2.99
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 2.99
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 2.99
HNRNPM-regulated splicing dependencies in prostate cancer 2.98
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 2.98
Total RNA-seq in ALL-SIL upon TLX1 knockdown 2.97
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 2.92
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 2.92
ENCODE Cold Spring Harbor Labs Long RNA-seq 2.91
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 2.91
Global transcriptome analysis of WT versus HEB-/- hESCs 2.82
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 2.8
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 2.79
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 2.79
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 2.78
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 2.78
Epigenome regulation during epidermal lineage commitment [RNA-seq] 2.76
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 2.75
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 2.75
Gene expression profiling of human and murine in vitro muscle differentiation 2.73
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 2.71
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 2.71
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 2.71
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 2.67
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 2.64
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 2.64
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 2.6
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 2.59
ARID1A regulates condensin II distribution and chromosomal partition 2.59
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 2.59
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 2.57
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 2.56
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 2.53
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 2.53
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 2.53
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 2.53
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 2.48
Gene expression profile in breast cancer cells 2.48
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 2.48
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 2.45
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 2.45
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 2.4
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 2.38
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 2.36
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 2.36
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 2.36
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 2.35
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 2.35
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 2.34
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 2.34
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 2.31
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 2.3
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 2.28
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 2.24
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 2.24
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 2.24
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 2.22
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 2.19
Entrectinib Resistance in a Neuroblastoma Xenograft Model 2.1
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 2.08
Microglia innatly develop within cerebral organoids 2.08
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 2.04
RNA seq comparison between scrambled and shGRP78 cells 1.97
RNA editing in nascent RNA affects pre-mRNA splicing 1.96
Dynamic reorganization of nuclear architecture during human cardiogenesis 1.94
Dynamic reorganization of nuclear architecture during human cardiogenesis [RNA-seq] 1.94
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 1.9
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 1.9
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 1.89
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 1.89
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 1.89
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 1.88
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 1.86
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 1.81
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.79
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 1.79
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 1.72
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 1.72
The cohesin complex prevents Myc-induced replication stress 1.66
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 1.64
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 1.63
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 1.62
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 1.62
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 1.62
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 1.51
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 1.44
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 1.43
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 1.4
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 1.39
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 1.34
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 1.34
Epigenetic reprogramming of melanoma cells by vitamin C treatment 1.33
Determination of tRNA aminoacylation levels by high throughput sequencing 1.32
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 1.32
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 1.31
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 1.3
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 1.29
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 1.29
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 1.28
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 1.26
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 1.26
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 1.22
mRNA recovered upon RNF219 IP. [RNA-IP] 1.21
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 1.2
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 1.2
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 1.18
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 1.16
MHC Transcriptomic landscape at haplotype-specific resolution 1.12
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 1.04
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 1.02
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 0.98
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.96
circNFIB suppresses lymphatic metastasis of pancreatic cancer 0.95
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 0.93
Identification of long noncoding RNAs in T-ALL cell lines 0.93
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 0.92
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 0.89
An siRNA screen identifies CHD4 as a target for epigenetic therapy 0.89
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 0.85
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 0.83
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 0.83
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence [RNA-seq] 0.83
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence 0.83
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 0.82
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.78
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 0.74
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 0.72
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 0.72
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 0.7
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 0.69
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 0.69
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 0.69
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 0.67
Ribosome profiling upon inhibition of eIF4A 0.64
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 0.63
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 0.62
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 0.57
TAF1 is critical for AE driven leukemogenesis 0.57
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 0.54
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 0.51
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 0.49
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 0.47
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 0.47
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 0.43
KSDM1b Role in Ewing Sarcoma 0.39
Zika virus infection reprograms global transcription of host cells to allow sustained infection 0.38
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 0.36
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 0.36
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 0.35
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 0.35
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 0.34
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 0.34
Transcriptome profiling of 5 human adenocarcinoma cell lines 0.3
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 0.29
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 0.27
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.27
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.24
ARS2 is a general suppressor of pervasive transcription [RNAseq] 0.2
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 0.18
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 0.18
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 0.17
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 0.16
RNA sequencing with KSHV infection and enrichment for circular RNAs 0.15
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 0.09
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.09
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.09
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 0.09
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 0.08
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 0.05
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 0.03
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 0.03
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation